Poging GOUD - Vrij
Quantum Sensing and Healthcare: Charting India's Next Frontier
Bio Spectrum
|August 2025
Quantum sensing can revolutionise healthcare by enabling early disease detection, precise diagnostics, and customized treatment plans. It detects subtle changes in fields, improving diagnoses for various diseases.
Technological advances in controlling the world of the ultra-small, made over the past few decades, have brought to fruition a field called “Quantum Sensing.” While it has applicability in a wide variety of problems, medical-diagnostics and healthcare-innovation would be revolutionised. Quantum sensors are ultrasensitive devices, capable of detecting the faintest of biological signals—be they magnetic, electric, thermal or even mechanical. They could enable game-changing applications in real-time diagnostics by detecting or measuring phenomena within single cells that were previously undetectable.
With a strategic investment in research, infrastructure, and translational pathways, India is today presented with a golden opportunity to play a leading role in this emerging domain, radically improving healthcare outcomes and building a global leadership in healthcare technologies.
National Quantum Mission: Catalysing Quantum Healthcare
India's National Quantum Mission (NQM), anchored in T-hubs like Indian Institute of Science (IISc) Bengaluru, Indian Institute of Technology (IIT) Madras, IIT Mumbai, IIT Delhi, has laid the groundwork for innovation across several domains in the field of Quantum Technology. To unlock the full potential for a revolutionary impact on healthcare, the NQM ought to give a high priority to the utilisation of quantum sensing for the biomedical field. A few example applications might include NV center-based subcellular imaging, optically pumped magnetometer (OPM)-driven brain scans, and quantum sensors for tissue oxygenation and metabolism etc. A clearly developed roadmap involving partnerships between the specialised academic establishment with leading clinics, regulatory integration, and funding for translational research could easily position India at the forefront of international players in this field.
Elevate Karnataka: Accelerating Deep-Tech Startups
Dit verhaal komt uit de August 2025-editie van Bio Spectrum.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Bio Spectrum
Bio Spectrum
Breaking Ground in Clinical Trials: India's Innovation Imperative
For decades, India has been a global powerhouse in pharmaceutical manufacturing. Yet in clinical trials, the crucial bridge between laboratory discoveries and patient access, the country’s performance has lagged behind its industrial capabilities.
5 mins
November 2025
Bio Spectrum
MOFs for Next-Gen Therapies
Susumu Kitagawa, Richard Robson and Omar M Yaghi have been awarded the Nobel Prize in Chemistry 2025 for the development of a new type of molecular architecture called metal-organic frameworks (MOFs), opening new avenues for applications such as drug delivery, biomedical imaging and personalised medicine.
2 mins
November 2025
Bio Spectrum
We aim to make bio-based industries a key pillar of the state's GSDP by 2030: Kerala CM
Kerala recently set the spotlight on its growing life sciences ecosystem with Bio Connect 3.0 – International Life Sciences Conclave & Expo, held on October 9 & 10, 2025, in Thiruvananthapuram. The event brought together global innovators, researchers, investors, and industry leaders to explore opportunities, collaborations, and advancements across biotechnology, healthcare, digital health, and allied sectors. Organised by the Kerala Life Sciences Industries Park (KLIP) and the Kerala State Industrial Development Corporation (KSIDC), this conclave featured thought-provoking discussions, visionary keynote sessions, and cutting-edge technology showcases.
3 mins
November 2025
Bio Spectrum
The AI Job Loss Threat Conundrum
There are assumptions that Artificial Intelligence (AI) will take away pharma and healthcare jobs. But many are of the opinion that AI will help to transform jobs as well as create new ones in the long run. How much pharma and healthcare companies invest in AI and cope with the latest AI innovations will determine who can survive and who will perish. Let's find out.
5 mins
November 2025
Bio Spectrum
Molbio announces collaboration with UE LifeSciences to expand iBreastExam globally
Molbio Diagnostics, a Goa-based point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies, and UE LifeSciences, a Philadelphia-based innovator engaged in the business of developing and manufacturing health technology solutions, with a primary focus on enabling early cancer detection technologies, have announced an exclusive collaboration, seeking to make early breast cancer detection accessible to millions of women in over 50 countries across the developing world.
1 min
November 2025
Bio Spectrum
CRO Reforms: Tilting Scale towards Accelerated Growth & Transparency
India's clinical research ecosystem is undergoing a major transformation, driven by a wave of regulatory reforms and rapid market expansion.
10 mins
November 2025
Bio Spectrum
When Spectra Speak: Letting AI Read the Fine Print of Biologics
Biologic characterisation has historically relied heavily on spectroscopy, which transforms chemical complexity into comprehensible fingerprints. Through the careful use of AI, supported by strict data procedures and scientific supervision, these fingerprints may be read more quickly & thoroughly.
5 mins
November 2025
Bio Spectrum
Working on our supply chain to set benchmarks in quality and further enhance India's position as a trusted clinical research supplier on a global scale
Abdos Lifesciences, which is committed to enabling science to thrive by delivering precision-engineered, high-performance laboratory consumables and instruments that meet the highest global standards, manufactures over 400 products across 12+ categories in automated cleanroom environments certified under ISO and CE-IVDR standards, ensuring sterility, traceability, and consistency crucial for decentralised and global clinical trials. Each product is barcoded, tamper-proof, and supported by easily accessible documentation such as Certificates of Analysis (COA), Technical Data Sheets (TDS). With a presence in more than 90 countries, Abdos Lifesciences ensures researchers worldwide receive reliable products and dedicated support, empowering science to advance seamlessly across borders and timelines. In an interview with BioSpectrum India Shrey Agarwal, CEO & Director, Abdos Lifesciences spoke to many issues including how the company is ensuring compliance with evolving global standards for products used in regulated clinical environments. Edited excerpts;
4 mins
November 2025
Bio Spectrum
Gene Solutions and AMPATH launch advanced genomics laboratory in Hyderabad
Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad.
1 min
November 2025
Bio Spectrum
Patient Consent - How is it different under medical ethics and data protection?
In the ethical and legal framework of medicine and law, consent has always existed. Within healthcare, it signifies the individual's right to be informed and to choose. However, in the digital era, consent assumes a broader function; it becomes the foundation for lawful processing of personal data. For the pharma and clinical-research sectors, this distinction carries significant implications. The Digital Personal Data Protection Act, 2023 (DPDPA), has redefined how personal and health-related data must be managed. This article explores why consent under data-protection law differs from medical consent, drawing lessons from the irregularities uncovered in the Ahmedabad clinical trials, and outlines the emerging compliance responsibilities under the DPDPA.
3 mins
November 2025
Listen
Translate
Change font size

